Tianfu International Biocity: Build Global Bioindustry-city
PR98288
CHENGDU, China, Oct. 14, 2022 /Xinhua=KYODO JBN/--
On Oct.10, Chengdu Tianfu Global International Biocity saw the signing of ten
project agreements totalling nearly 9B CNY in value and covering modern
biopharmaceuticals, innovative chemical drugs, sophisticated medical
apparatuses and other important fields.
Geneseeq, a Chinese genetic disease testing giant, intends to invest in a local
facility and industrialization base of genetic infection and tumor diagnosis as
southwestern China-based its headquarters. They're devoted to becoming
Geneseeq's second head office in China as well as the pacesetter of testing &
diagnosis in midwestern China.
Shanghai Siyi Intelligent Technology Co., Ltd., a leading Chinese soft robotics
manufacturer, will build a rehabilitation platform that integrates the
hospital, community and family. At the same time, Siyi will locate its
operating head office, listed company office and manufacturing facility to
Tianfu International Biocity.
"Tianfu International Biocity helps us with both investment and subsidy to
support the projects and solve investment and financing problems. From the
perspective of upstream and downstream analysis, improve the industry chain and
save us a lot time in upstream-downstream communication," said Yin Ganggang,
founder of Siyi.
"The signing of these agreements will make bioindustrial innovation
transformation. In the future, the biocity will continue to build more project
clusters that consistently gain in magnitude and promote the industry of
pharmaceuticals," said the spokesman of Chengdu Tianfu International Biocity.
Commenced in March 2016 and located in southwestern Shuangliu (part of Chengdu,
the capital of Sichuan), Chengdu Tianfu International Biocity has a planned
area of around 44 square kilometers. The Biocity includes five industries, i.e.
biopharmaceuticals, innovative chemical drugs, high-performance medical
equipment, professional outsourcing service and health service. These
industries are intended to promote the close combination of the industry chain,
innovation chain and supply chain, therefore adding to the local driving force
and competitiveness of the modern industry.
Since foundation, Tianfu International Biocity has seen its bioindustry gain in
economic contribution and competitiveness. The first-phase 9-km city framework
is already in place.
In order to attract investments from biopharmaceutical professionals, Chengdu
Tianfu International Ecocity attaches importance to urban livability, constant
improvements in urban functions, worker-inhabitant balance improvement and life
convenience in order to meet the residential requirements of local people and
company employees. Yong'an Lake Urban Forest Park, Incubator Shopping Street,
community complexes and other business models are contributing step by step to
such consumer markets as food, hospitality, travel, tourism, shopping and
recreation. Now, Chengdu Tianfu International Biocity is on its way to becoming
a global base of innovative biopharmaceuticals.
Source: Chengdu Tianfu Global International Biocity
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。